NCT07216404 - Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 20, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Lung Non-Small Cell CarcinomaUnipolar Depression

Interventions

PROCEDURE

Biospecimen Collection

Undergo blood and urine sample collection

OTHER

Counseling

Participate in therapy sessions

OTHER

Interview

Ancillary studies

DRUG

Psilocybin

Given PO

OTHER

Survey Administration

Ancillary studies

Trial Locations (1)

Ohio State University Comprehensive Cancer Center, Columbus

All Listed Sponsors

lead

Alan Davis

OTHER